We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
-0.18%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$5.34B
AUM Growth
-$237M
Cap. Flow
-$130M
Cap. Flow %
-2.43%
Top 10 Hldgs %
17.36%
Holding
1,615
New
114
Increased
629
Reduced
604
Closed
130

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$17.6M
2
AAPL icon
Apple
AAPL
+$16.6M
3
NVDA icon
NVIDIA
NVDA
+$14.2M
4
IDXX icon
Idexx Laboratories
IDXX
+$13.7M
5
XPO icon
XPO
XPO
+$13.2M

Sector Composition

Rank Sector Weight
1 Technology 18.05%
2 Financials 11.09%
3 Healthcare 10.47%
4 Consumer Discretionary 9.45%
5 Industrials 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KTB icon
301
Kontoor Brands
KTB
$4.63B
$4.24M 0.08%
84,973
-959
-1% -$53.1K
GSK icon
302
GSK
GSK
$104B
$4.24M 0.08%
88,713
+2,845
+3% +$143K
PLTR icon
303
Palantir
PLTR
$293B
$4.16M 0.08%
173,158
-147,158
-46% -$3.59M
CHPT icon
304
ChargePoint
CHPT
$142M
$4.14M 0.08%
10,366
+5,123
+98% +$2.38M
AYI icon
305
Acuity Brands
AYI
$10.1B
$4.14M 0.08%
23,899
-75
-0.3% -$13.1K
NSC icon
306
Norfolk Southern
NSC
$75B
$4.12M 0.08%
17,226
+1,164
+7% +$298K
PFF icon
307
iShares Preferred and Income Securities ETF
PFF
$13.3B
$4.1M 0.08%
105,661
+10,650
+11% +$418K
BNY
308
Bank of New York Mellon
BNY
$106B
$4.08M 0.08%
78,799
-432
-0.5% -$22.5K
ACI icon
309
Albertsons Companies
ACI
$5.63B
$4.08M 0.08%
131,165
-27,389
-17% -$721K
SMG icon
310
ScottsMiracle-Gro
SMG
$3.97B
$4.08M 0.08%
27,852
+25,072
+902% +$4.11M
ITM icon
311
VanEck Intermediate Muni ETF
ITM
$2.14B
$4.03M 0.08%
78,732
+11,945
+18% +$620K
KEYS icon
312
Keysight
KEYS
$53.4B
$3.98M 0.07%
24,203
-5,453
-18% -$915K
NOW icon
313
ServiceNow
NOW
$114B
$3.95M 0.07%
31,765
-740
-2% -$89.6K
TDG icon
314
TransDigm Group
TDG
$69.9B
$3.95M 0.07%
6,329
-8,882
-58% -$5.55M
CL icon
315
Colgate-Palmolive
CL
$73.3B
$3.94M 0.07%
52,112
-1,722
-3% -$137K
MU icon
316
Micron Technology
MU
$988B
$3.93M 0.07%
55,430
+9,493
+21% +$713K
BSX icon
317
Boston Scientific
BSX
$68.4B
$3.93M 0.07%
90,464
-463
-0.5% -$20.5K
WCN
318
Waste Connections
WCN
$41.9B
$3.92M 0.07%
31,153
-1,474
-5% -$186K
PPG icon
319
PPG Industries
PPG
$25B
$3.9M 0.07%
27,306
-1,172
-4% -$188K
MUB icon
320
iShares National Muni Bond ETF
MUB
$45.2B
$3.89M 0.07%
33,459
-516
-2% -$60.5K
VNT icon
321
Vontier
VNT
$4.49B
$3.89M 0.07%
115,699
+2,623
+2% +$89.1K
TECK icon
322
Teck Resources
TECK
$30.7B
$3.84M 0.07%
154,053
+21,613
+16% +$495K
OXY icon
323
Occidental Petroleum
OXY
$55.6B
$3.84M 0.07%
129,739
+13,798
+12% +$368K
CNC icon
324
Centene
CNC
$30.1B
$3.82M 0.07%
61,237
-51,033
-45% -$3.41M
DOW icon
325
Dow Inc
DOW
$21.7B
$3.77M 0.07%
65,455
-13,376
-17% -$819K

Similar funds

Oppenheimer & Co's Q3 2021 Portfolio in Review

As of Q3 2021, Oppenheimer & Co held 1,615 positions worth $5.34B, down 4.2% from $5.58B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Oppenheimer & Co's Q3 2021 filing shows 114 new, 629 increased, 604 reduced and 130 closed positions. Its largest new stake was Global X S&P 500 Covered Call ETF: 1,004,600 shares worth $488K. The largest sale was Microsoft, an estimated $17.6M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q3 2021 buy was Global X S&P 500 Covered Call ETF: 1,004,600 shares worth $488K.
  • Oppenheimer & Co added most to Invesco Ultra Short Duration ETF in Q3 2021, an estimated $9.29M increase.
  • Oppenheimer & Co's biggest Q3 2021 reduction was Microsoft, cutting an estimated $17.6M.
  • Oppenheimer & Co fully exited Pricesmart in Q3 2021, selling an estimated $6.18M.
  • Oppenheimer & Co's ten largest holdings make up 17% of its $5.34B portfolio in Q3 2021.
  • Oppenheimer & Co opened 114 new positions and closed 130 in Q3 2021.
  • Oppenheimer & Co's portfolio value fell 4.2% quarter-over-quarter to $5.34B.

Based on Oppenheimer & Co's 13F filing for Q3 2021, filed 12 Nov 2021.